GCTK Earnings Glucotrack, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–48 of 48
| Q2 2026 | 2026-06-30 | 22.80 | 2026-08-14 | 10-Q |
| Q1 2026 | 2026-03-31 | 79.50 | 2026-05-14 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -695.40 | 2026-03-30 | 10-K |
| FY 2025 | 2025-12-31 | 936.60 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | 139.20 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | 288.60 | 2025-08-14 | 10-Q |
| Q1 2025 | 2025-03-31 | 1204.20 | 2025-05-14 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 82014.00 | 2025-03-31 | 10-K |
| FY 2024 | 2024-12-31 | 123180.00 | 2025-03-31 | 10-K |
| Q3 2024 | 2024-09-30 | 32760.00 | 2024-11-14 | 10-Q |
| Q2 2024 | 2024-06-30 | 29520.00 | 2024-08-13 | 10-Q |
| Q1 2024 | 2024-03-31 | -21114.00 | 2024-05-15 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | 62640.00 | 2024-03-28 | 10-K |
| FY 2023 | 2023-12-31 | 61524.00 | 2024-03-28 | 10-K |
| Q3 2023 | 2023-09-30 | -882.00 | 2023-11-14 | 10-Q |
| Q2 2023 | 2023-06-30 | 486.00 | 2023-08-14 | 10-Q |
| Q1 2023 | 2023-03-31 | -720.00 | — | — |
| FY 2022 | 2022-12-31 | 2610.00 | — | — |
| Q3 2022 | 2022-09-30 | -540.00 | 2022-11-14 | 10-Q |
| Q2 2022 | 2022-06-30 | -630.00 | 2022-08-15 | 10-Q |
| FY 2021 | 2021-12-31 | 2340.00 | 2022-03-31 | 10-K |
| Q3 2021 | 2021-09-30 | -450.00 | 2021-11-15 | 10-Q |
| Q2 2021 | 2021-06-30 | -540.00 | 2021-08-16 | 10-Q |
| FY 2020 | 2020-12-31 | 1710.00 | 2021-04-13 | 10-K |
| Q3 2020 | 2020-09-30 | -270.00 | 2020-11-12 | 10-Q |
| Q2 2020 | 2020-06-30 | -360.00 | 2020-08-14 | 10-Q |
| FY 2019 | 2019-12-31 | -180.00 | 2020-04-14 | 10-K |
| Q3 2019 | 2019-09-30 | -90.00 | 2019-11-13 | 10-Q |
| Q2 2019 | 2019-06-30 | -90.00 | 2019-08-14 | 10-Q |
| FY 2018 | 2018-12-31 | -42660.00 | 2019-04-15 | 10-K |
| Q3 2018 | 2018-09-30 | -2790.00 | 2018-11-14 | 10-Q |
| Q2 2018 | 2018-06-30 | -2970.00 | 2018-08-14 | 10-Q |
| FY 2017 | 2017-12-31 | -16830.00 | 2018-03-30 | 10-K |
| Q3 2017 | 2017-09-30 | -3960.00 | — | — |
| Q2 2017 | 2017-06-30 | -4320.00 | — | — |
| FY 2016 | 2016-12-31 | -9720.00 | 2017-03-31 | 10-K |
| Q3 2016 | 2016-09-30 | -2700.00 | 2016-11-14 | 10-Q |
| Q2 2016 | 2016-06-30 | -2700.00 | 2016-08-15 | 10-Q |
| FY 2015 | 2015-12-31 | -10350.00 | 2016-03-30 | 10-K |
| Q3 2015 | 2015-09-30 | -1980.00 | 2015-11-16 | 10-Q |
| Q2 2015 | 2015-06-30 | -2970.00 | 2015-08-14 | 10-Q |
| FY 2014 | 2014-12-31 | 3330.00 | 2015-03-31 | 10-K |
| Q3 2014 | 2014-09-30 | -1440.00 | 2014-11-14 | 10-Q |
| Q2 2014 | 2014-06-30 | 7020.00 | 2014-08-19 | 10-Q |
| FY 2013 | 2013-12-31 | -17550.00 | — | — |
| Q3 2013 | 2013-09-30 | -1440.00 | — | — |
| Q2 2013 | 2013-06-30 | -1170.00 | — | — |
| FY 2012 | 2012-12-31 | -4680.00 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.